Progressive Myoclonic Epilepsy

Gene: CLN8

Green List (high evidence)

CLN8 (CLN8, transmembrane ER and ERGIC protein)
EnsemblGeneIds (GRCh38): ENSG00000182372
EnsemblGeneIds (GRCh37): ENSG00000182372
OMIM: 607837, ClinGen, DECIPHER
CLN8 is in 12 panels

2 reviews

Zornitza Stark (Victorian Clinical Genetics Services)

Green List (high evidence)

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Ceroid lipofuscinosis, neuronal, 8, MIM# 600143 Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant, MIM# 610003

Noor Al-Ali (Other)

Green List (high evidence)

Variants in this gene are associated with two subtypes of rare neuronal ceroid lipofuscinosis (NCLs):
- Classical subtype: The more severe form of CLN8-related disease typically occurs between ages 2 and 7. This subtype is characterized by myoclonic epilepsy, pronounced decline in intellectual function, loss of speech, vision loss, and increasing difficulty walking.
- Northern epilepsy subtype: The less severe subtype, known as Northern epilepsy, shows slower progression compared to the classical form. This condition is characterized by onset between ages 5 and 10, intractable tonic-clonic or complex partial seizures without myoclonic epilepsy, and decline in intellectual function.
Created: 19 Nov 2025, 11:55 p.m. | Last Modified: 19 Nov 2025, 11:55 p.m.
Panel Version: 0.22

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Progressive vision loss; developmental regression; seizures; ataxia; speech and language difficulties; myoclonus; EEG abnormalities; cerebral atrophy; cerebellar atrophy; autofluorescent lipopigment in neurons; intracellular fingerprint profiles on ultrastructural analysis; intracellular curvilinear profiles on ultrastructural analysis; onset at 2 to 7 years of age; most patients lose ambulation two years after onset.

Publications

Mode of pathogenicity
Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • Royal Melbourne Hospital
Phenotypes
  • Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant 610003
  • Ceroid lipofuscinosis, neuronal, 8 600143
OMIM
607837
ClinGen
CLN8
DECIPHER
CLN8
Clinvar variants
Variants in CLN8
Penetrance
None
Publications
Panels with this gene

History Filter Activity

21 Nov 2025, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: cln8 has been classified as Green List (High Evidence).

21 Nov 2025, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: CLN8 were set to

9 Jan 2020, Gel status: 3

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Bryony Thompson (Royal Melbourne Hospital)

gene: CLN8 was added gene: CLN8 was added to Progressive Myoclonic Epilepsy_RMH. Sources: Expert Review Green,Royal Melbourne Hospital Mode of inheritance for gene: CLN8 was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: CLN8 were set to Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant 610003; Ceroid lipofuscinosis, neuronal, 8 600143